EvoEndo® Surpasses 3,000 Sedation-Free Transnasal Endoscopy Procedures Nationwide
EvoEndo®, Inc. (EvoEndo) today announced that practitioners have now completed more than 3,000 sedation-free transnasal endoscopy (TNE) procedures using the EvoEndo Endoscopy System, as implementation expands to more than 70 locations nationwide.
“Reaching 3,000 cases is an important milestone, but what matters most is what it represents for patients, families, and physicians,” said Jonathan Hartmann, CEO of EvoEndo. “Every case reflects greater access to sedation-free endoscopy and the trust our partners place in EvoEndo.”
The EvoEndo footprint has expanded coast to coast and throughout the heartland, providing more patients access to sedation-free TNE in cities including Boston, Cleveland, Milwaukee, Birmingham, Orlando, and San Francisco. Several hospitals have performed more than 300 cases, including Children’s Mercy Kansas City and Phoenix Children’s Hospital.
More than 100 practitioners have adopted the EvoEndo Endoscopy System. “We have been thrilled to offer our patients a less invasive option for managing and monitoring their eosinophilic esophagitis,” said Dr. Eitan Rubinstein, Assistant Professor in Pediatrics at Harvard Medical School and Attending Physician in the Department of Gastroenterology and Nutrition at Boston Children’s Hospital.
